NASDAQ: COSM | Healthcare / Drug Manufacturers / USA |
1.35 | -0.0700 | -4.93% | Vol 190.61K | 1Y Perf 639.58% |
Oct 3rd, 2023 16:00 DELAYED |
BID | 1.33 | ASK | 1.36 | ||
Open | 1.40 | Previous Close | 1.42 | ||
Pre-Market | - | After-Market | 1.36 | ||
- - | 0.01 0.74% |
Target Price | - | Analyst Rating | — — 0.00 | |
Potential % | - | Finscreener Ranking | — - | |
Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ☆ 30.75 | |
Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ☆ 26.25 | |
Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
Price Range Ratio 52W % | 1.58 | Earnings Rating | — | |
Market Cap | 14.34M | Earnings Date | 13th Nov 2023 | |
Alpha | 0.02 | Standard Deviation | 0.84 | |
Beta | 3.01 |
Today's Price Range 1.301.40 | 52W Range 0.990023.84 | 5 Year PE Ratio Range -83.80150.00 |
Summary:
Sell
Technical Indicators: | Neutral |
Moving Averages: | Strong Sell |
Performance | |||
---|---|---|---|
1 Week | -25.26% | ||
1 Month | 20.34% | ||
3 Months | -54.49% | ||
6 Months | -59.77% | ||
1 Year | 639.58% | ||
3 Years | -59.31% | ||
5 Years | -65.37% | ||
10 Years | -77.81% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 115.45 | |||
ROE last 12 Months | -946.57 | |||
ROA (5Y Avg) | -7.90 | |||
ROA last 12 Months | -81.26 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -113.19 | |||
Return on invested Capital Q | -5.65 | |||
Return on invested Capital Y | -43.83 | |||
Assets Turnover | 0.90 | |||
Receivables Turnover | 1.40 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
-0.10 | ||||
14.14 | ||||
1.21 | ||||
16.20 | ||||
-9.90 | ||||
-7.31 | ||||
17.64 | ||||
0.33 | ||||
73.23M | ||||
Forward PE | - | |||
PEG | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.80 | ||||
1.10 | ||||
0.28 | ||||
6.72 | ||||
-0.20 | ||||
Leverage Ratio | 10.50 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
15.60 | ||||
-1.40 | ||||
-0.50 | ||||
-11.90 | ||||
-7.86 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
38.30M | ||||
3.62 | ||||
16.99 | ||||
30.40 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q01 2024 | - | 0.02 | - |
Q03 2022 | - | -0.08 | - |
Q02 2022 | - | -0.93 | - |
- | - | - | - |
- | - | - | - |
- | - | - | - |
- | - | - | - |
- | - | - | - |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
- | - | - | - |
- | - | - | - |
- | - | - | - |
- | - | - | - |
Next Report Date | 13th Nov 2023 |
Estimated EPS Next Report | - |
Estimates Count | - |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 190.61K |
Shares Outstanding | 10.62K |
Shares Float | 9.52M |
Trades Count | 843 |
Dollar Volume | 256.30K |
Avg. Volume | 2.04M |
Avg. Weekly Volume | 994.28K |
Avg. Monthly Volume | 3.54M |
Avg. Quarterly Volume | 1.60M |
Cosmos Holdings Inc. (NASDAQ: COSM) stock closed at 1.42 per share at the end of the most recent trading day (a -9.55% change compared to the prior day closing price) with a volume of 507.52K shares and market capitalization of 14.34M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 85 people. Cosmos Holdings Inc. CEO is Panagiotis Drakopoulos.
The one-year performance of Cosmos Holdings Inc. stock is 639.58%, while year-to-date (YTD) performance is -68.86%. COSM stock has a five-year performance of -65.37%. Its 52-week range is between 0.99 and 23.84, which gives COSM stock a 52-week price range ratio of 1.58%
Cosmos Holdings Inc. currently has a PE ratio of -0.10, a price-to-book (PB) ratio of 14.14, a price-to-sale (PS) ratio of 1.21, a price to cashflow ratio of 16.20, a PEG ratio of -, a ROA of -81.26%, a ROC of -113.19% and a ROE of -946.57%. The company’s profit margin is -7.86%, its EBITDA margin is -0.50%, and its revenue ttm is $38.30 Million , which makes it $3.62 revenue per share.
Of the last four earnings reports from Cosmos Holdings Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Cosmos Holdings Inc.’s next earnings report date is 13th Nov 2023.
The consensus rating of Wall Street analysts for Cosmos Holdings Inc. is — (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Cosmos Holdings Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Cosmos Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Cosmos Holdings Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 35.70, ATR14 : 0.21, CCI20 : 1.50, Chaikin Money Flow : -0.06, MACD : 0.06, Money Flow Index : 75.62, ROC : 10.08, RSI : 46.46, STOCH (14,3) : 27.59, STOCH RSI : 0.00, UO : 39.14, Williams %R : -72.41), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Cosmos Holdings Inc. in the last 12-months were: Grigorios Siokas (Buy at a value of $8 543 468), Siokas Grigorios (Buy at a value of $449 998)
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | - | - | - |
Cosmos Holdings Inc is engaged in the research, development, and commercialization of pharmaceutical products and medicines across the European Union member states. It offers over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, and wholesalers and retail healthcare providers.
CEO: Panagiotis Drakopoulos
Telephone: +1 312 536-3102
Address: 141 West Jackson Boulevard, Chicago 60604, IL, US
Number of employees: 85
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.